NEW
Stock Screener with Intrinsic Value
Alnylam Pharmaceuticals, Inc. (ALNY)
Last Price$238.0(1.1%)
Market Cap$30.1B
$2,094.8M
+21.5% YoY
($332.3M)
-34.8% YoY
($1,470.1M)
Net Debt to FCF - (91.5x)
$16.1M
0.8% margin
ALNY Income Statement
ALNY Income Statement Overview
Crunching data... Almost there!
ALNY Income statement key metrics
Crunching data... Almost there!
ALNY Balance Sheet
ALNY Balance Sheet Overview
Crunching data... Almost there!
ALNY Balance Sheet Metrics
Crunching data... Almost there!
ALNY Cash Flow Statement
ALNY Cash Flow Statement Overview
Crunching data... Almost there!
ALNY Cash Flow Statement key metrics
Crunching data... Almost there!
ALNY Financials
Crunching data... Almost there!
FAQ
What is the Alnylam Pharmaceuticals, Inc. (ALNY) revenue?
The Alnylam Pharmaceuticals, Inc. (ALNY) revenue is $1,828.3M, reflecting a year-over-year (YoY) growth of +76.2% YoY.
What is the Alnylam Pharmaceuticals, Inc. (ALNY) Net Income?
The Alnylam Pharmaceuticals, Inc. (ALNY) Net Income is ($440.2M), showcasing a YoY growth of -61.1% YoY.
What is Alnylam Pharmaceuticals, Inc. (ALNY) net debt?
What is the Alnylam Pharmaceuticals, Inc. (ALNY) Free Cash Flow (FCF)?
The Alnylam Pharmaceuticals, Inc. (ALNY) Free Cash Flow (FCF) stands at $41.9M, accounting for a 2.3% margin.